Father wins battle to get anti-acne drug reports

EU medical authorities have been sharply criticised by the European Ombudsman over their refusal to give access to an Irish citizen who sought information on adverse reactions to the controversial anti-acne drug, Roaccutane.

The European Medicines Agency (EMEA) was yesterday instructed to supply the information to Dublin accountant, Liam Grant, as requested on the recommendation of the European Ombudsman, P Nikiforos Diamandouros.

The EU Ombudsman said the EMEA had failed to provide valid and adequate grounds for its refusal to make such information available.